Hodgkin Lymphoma
Feature
Woman who faked cancer gets 5 years in prison
Feature
Third-generation Black woman physician makes cancer research history
African American surgeon helped found ASCO and collaborated with her father to achieve lasting breakthroughs in chemotherapy.
Feature
Ex–hospital porter a neglected giant of cancer research
An Indian immigrant who once emptied bedpans in a Boston hospital went on to become the “father of chemotherapy.”
From the Journals
‘Unprecedented crisis’: Hodgkin drug shortage persists
Supply chain problems have triggered shortages of a drug to treat Hodgkin lymphoma, igniting a search for substitutes.
Feature
When CPI fails, HL patients should get timely allo-HCT
New data suggest that physicians should refer Hodgkin lymphoma patients for allogeneic HCT without delay when PD-1 treatments fail.
Feature
Survivor’s story foreshadows one of oncology’s greatest successes
In 1992, a young New Yorker was among the first Hodgkin lymphoma patients to undergo a successful bone marrow transplant. Three decades later,...
Feature
Repurposed drug could revolutionize stem cell transplantation
Abatacept to prevent for acute graft-versus-host disease is a game changer for patients receiving hematopoietic stem cell transplants who lack...
From the Journals
Hodgkin-directed therapy may benefit patients with rare CLL subtype
Patients diagnosed with an uncommon subtype of chronic lymphocytic lymphoma show improved outcomes from Hodgkin-directed treatments.
Feature
DKMS: Small nonprofit to world’s largest stem cell donor registry
A German family’s tragedy launched DKMS, a multinational organization whose goal is to “delete blood cancer.”
From the Journals
Frontline brentuximab vedotin shows promise in high-risk pediatric Hodgkin lymphoma
From the Journals
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...